Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
about
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanismRhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction.Cerivastatin-induced rhabdomyolysis: 11 case reports.Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions.A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.Simvastatin: two decades in a circle.Is There Potential for Repurposing Statins as Novel Antimicrobials?Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.Clinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network.Potential statin-drug interactions: prevalence and clinical significanceEffect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers.Evaluation of potential interaction between vinorelbine and clarithromycin.Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.Development and Application of a Mechanistic Pharmacokinetic Model for Simvastatin and its Active Metabolite Simvastatin Acid Using an Integrated Population PBPK Approach.Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin.HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions.Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial.A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
P2860
Q24603957-01D203E3-6D31-46DC-9830-A2D2FC6806F0Q33148996-5DB36877-9844-41E7-AA7C-997B41946006Q34592173-690B68A5-93A3-4D04-AE75-66FBD58F7AB3Q36065199-F75CEA1C-3D2B-496A-88C5-9A14FA7D4DA8Q36203546-B524BA74-B442-421E-81F4-FDBF2CC1AB5AQ37165690-8FF0936D-2470-49E6-9DC9-6760641E59ADQ37203857-D8A221A8-1C1D-48BA-BE0B-D248F15A719EQ37473376-90207A63-4291-4C5A-99A2-C5913F1057C2Q37473382-F49DD596-066A-4E4A-B38B-45903AF47105Q37724896-75496B18-6BB1-4D09-8E96-7B972793D134Q39062284-714818BE-60F8-4B0D-A84B-28A739294E08Q39997520-0910AACB-C1D7-48BB-B49C-CFB1B476C1A2Q40230832-D7581367-833A-4F3D-BD29-82AE5B0FB16AQ41759104-8C37EAD0-D2F1-4DF2-B207-3D0BBAAC744AQ42704777-926A9493-2417-4EB8-9E84-501BD98DF55FQ44179752-2A1229BF-5E95-45D7-80A0-DD8D9D4B561EQ44456918-A8E4B771-4884-482F-807E-395C31572D18Q45230084-D61F89C0-2736-4F02-B361-FE4E1F77CA05
P2860
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
@ast
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
@en
type
label
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
@ast
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
@en
prefLabel
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
@ast
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
@en
P2860
P356
P1476
Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
@en
P2093
P2860
P356
10.1345/APH.10177
P407
P577
2001-01-01T00:00:00Z